Clinical Trials List
2022-12-01 - 2025-12-31
Phase II
Not yet recruiting2
ICD-10M34.0
Progressive systemic sclerosis
ICD-10M34.1
CR(E)ST syndrome
ICD-10M34.2
Systemic sclerosis induced by drug and chemical
ICD-10M34.89
Other systemic sclerosis
ICD-10M34.9
Systemic sclerosis, unspecified
ICD-9710.1
Systemic sclerosis
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 張詩欣 無
- Po-Hao Huang 無
- 黃建中 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 呂政勳 無
- 黃昱森 無
- 郭佑民 無
- CHIEH-YU SHEN 無
- KO-JEN LI 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
200 participants
